378.13
0.30%
1.13
United Therapeutics Corp Stock (UTHR) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
10.25%
677.70
|
614.70 | 609.40 | 596.50 | 506.90 |
Cost Of Revenue |
2.68%
72.90
|
71.00 | 70.10 | 64.10 | 52.30 |
Gross Profit |
11.24%
604.80
|
543.70 | 539.30 | 532.40 | 454.60 |
Operating Expenses
|
12.38%
248.50
|
283.60 | 212.30 | 219.00 | 170.20 |
Interest Income/Expense |
11.92%
13.30
|
15.10 | 15.60 | 14.80 | 13.80 |
Benefits Costs and Expenses |
12.59%
279.10
|
319.30 | 257.60 | 261.30 | 215.00 |
Costs And Expenses |
9.36%
321.40
|
354.60 | 282.40 | 283.10 | 222.50 |
Operating Income/Loss |
36.99%
356.30
|
260.10 | 327.00 | 313.40 | 284.40 |
Nonoperating Income/Loss |
19.83%
42.30
|
35.30 | 24.80 | 21.80 | 7.50 |
Income/Loss From Continuing Operations Before Tax |
34.94%
398.60
|
295.40 | 351.80 | 335.20 | 291.90 |
Income Tax Expense/Benefit |
17.50%
92.00
|
78.30 | 84.20 | 76.00 | 51.00 |
Income/Loss From Continuing Operations After Tax |
41.23%
306.60
|
217.10 | 267.60 | 259.20 | 240.90 |
Net Income/Loss
|
41.23%
306.60
|
217.10 | 267.60 | 259.20 | 240.90 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
46,900%
47.00
|
0.10 | 46.90 | 46.90 | 46.30 |
Diluted Average Shares |
49,600%
49.70
|
0.10 | 49.70 | 49.50 | 49.60 |
Basic Earnings Per Share |
41.74%
6.52
|
4.60 | 5.71 | 5.53 | 5.20 |
Diluted Earnings Per Share |
42.49%
6.17
|
4.33 | 5.38 | 5.24 | 4.86 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):